We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medgenics(Regs) | LSE:MEDG | London | Ordinary Share | COM SHS USD0.0001 (REGS) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 302.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMEDG TIDMMEDU
RNS Number : 2469I
Medgenics Inc
23 July 2012
Press Release 23 July 2012
Medgenics, Inc.
("Medgenics" or the "Company")
Medgenics Announces Registration of Shares to be Issued Upon Exercises of Warrants Listed on NYSE MKT
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of Biopump(TM) , a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced the availability of a current prospectus following the effectiveness of its registration in the United States of common stock issuable upon the exercise of outstanding warrants to purchase 2,829,000 shares of common stock.
The warrants were originally issued in the Company's initial public offering in the United States in April 2011 and are listed on the NYSE MKT (formerly the NYSE Amex) under the symbol "MDGN.WS." Each warrant is exercisable for one share of the Company's common stock, listed on the NYSE MKT under the symbol "MDGN."
The shares of common stock issuable upon exercise of the warrants are being offered by the Company pursuant to a registration statement previously filed and declared effective by the Securities and Exchange Commission on July 20, 2012. Electronic copies of the prospectus may be obtained at the Securities and Exchange Commission's website at http://www.sec.gov. Copies of the prospectus may also be obtained from Corporate Stock Transfer, Inc., as warrant agent, by contacting it at 3200 Cherry Creek Drive South, Suite 4300, Denver, Colorado 80209, or (303) 282-4800.
In order to exercise a warrant, the holder must deliver to Corporate Stock Transfer, Inc., 3200 Cherry Creek Drive South, Suite 4300, Denver, Colorado 80209:
-- the original warrant certificate
-- a completed and executed exercise form located on the reverse side of the warrant certificate and
-- full payment of the exercise price, by certified check payable to "Medgenics Warrant Exercise Account" or by wire transfer of immediately available funds.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Medgenics
Medgenics is developing and commercializing Biopump(TM), a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient's own skin biopsy for the treatment of a range of chronic diseases including anemia, hepatitis, and hemophilia, among others.
For further information, contact:
Medgenics, Inc. Phone: +972 4 902 8900 Dr. Andrew L. Pearlman andrew.pearlman@medgenics.com Abchurch Communications Phone: +44 207 398 7719 Adam Michael Joanne Shears Jamie Hooper jamie.hooper@abchurch-group.com Nomura Code Securities (NOMAD and Phone: +44 207 776 1200 Joint Broker) Jonathan Senior Giles Balleny SVS Securities plc (Joint Broker) Phone: +44 207 638 5600 Alex Mattey Ian Callaway
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCKXLBLLDFXBBD
1 Year Medgenics(Regs) Chart |
1 Month Medgenics(Regs) Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions